US · PNTG
The Pennant Group, Inc.
- Sector
- Healthcare · Medical - Care Facilities
- Headquarters
- Eagle, ID 83616
- Website
- pennantgroup.com
Price · as of 2025-12-31
$31.30
Market cap 1.17B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $31.62 | +1.02% |
| Intrinsic Value(DCF) | $1,123.31 | +3,488.85% |
| Graham-Dodd Method(GD) | $7.04 | -77.51% |
| Graham Formula(GF) | $36.75 | +17.42% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | $3.71 | $12.13 | |||
| 2019 | $27.57 | $38.96 | $25.89 | $0.00 | $2.35 |
| 2020 | $57.30 | $70.28 | $5.80 | $3.88 | $12.84 |
| 2021 | $14.15 | $74.92 | $0.08 | $1.74 | $1.90 |
| 2022 | $12.76 | $72.95 | $0.00 | $2.57 | $3.52 |
| 2023 | $18.39 | $29.75 | $0.00 | $3.89 | $10.16 |
| 2024 | $22.21 | $27.31 | $78.19 | $8.88 | $24.97 |
| 2025 | $33.82 | $31.62 | $677.32 | $7.04 | $36.75 |
AI valuation
Our deep-learning model estimates The Pennant Group, Inc.'s (PNTG) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $31.62
- Current price
- $31.30
- AI upside
- +1.02%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1,123.31
+3,488.85% upside
Graham-Dodd
$7.04
-77.51% upside
Graham Formula
$36.75
+17.42% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| PNTG | The Pennant Group, Inc. | $31.30 | 1.17B | +1% | +3,489% | -78% | +17% | 39.52 | 3.51 | 1.23 | 26.38 | 215.84 | -11.23 | 12.92% | 5.42% | 3.12% | 9.45% | 5.80% | 3.59% | 1.36 | 7.70 | 1.14 | 0.95 | 7.17 | 1831.00% | 3631.00% | 5935.00% | 4.13% | 0.33 | 7.37% | 0.00% | 0.00% | 0.00% | 31.23 | 33.24 | 1.69 | 2.49 |
| AMN | AMN Healthcare Services, … | $19.48 | 748.3M | +170% | -58% | — | — | — | 1.22 | 0.29 | 15.68 | — | -1.98 | 22.93% | 1.21% | -3.51% | 0.00% | 1.94% | 0.00% | 1.30 | 0.73 | 0.94 | 0.72 | 7.90 | -3558.00% | -849.00% | 1250.00% | 34.29% | 0.47 | 16.66% | 0.00% | — | 36.62% | 47.79 | 5.88 | 0.58 | 2.47 |
| BCAX | Bicara Therapeutics Inc. … | $16.78 | 919.24M | — | — | — | — | -13.25 | 1.83 | — | -5.00 | -52.99 | 1.83 | 0.00% | — | — | -19.14% | 1967.97% | -16.93% | 0.00 | — | 27.93 | 27.22 | 5.94 | 2500.00% | — | 6190.00% | -8.31% | -4.16 | 1787.22% | 0.00% | 0.00% | 28.78% | -5.00 | -5.50 | — | 6.99 |
| CRMD | CorMedix Inc. | $7.13 | 561.77M | — | +1,092,258% | — | — | -35.17 | 7.45 | 14.50 | -30.53 | — | 7.61 | 92.66% | -51.43% | -41.24% | -23.17% | -146.77% | -17.85% | 0.01 | -614.10 | 3.39 | 3.05 | 2.11 | -6703.00% | — | 3096.00% | -8.05% | -1.50 | -358.96% | 0.00% | 0.00% | 0.00% | -25.91 | -11.42 | 13.33 | 7.62 |
| EYPT | EyePoint Pharmaceuticals,… | $17.56 | 1.45B | +9,195% | -75% | — | — | -3.07 | 1.19 | 9.28 | -0.41 | -11.16 | 1.19 | 91.42% | -337.06% | -302.43% | -43.42% | 403.05% | -33.83% | 0.06 | -10418.14 | 7.81 | 7.57 | 0.60 | 2747.00% | -597.00% | 800187.00% | -32.46% | -2.57 | 360.01% | 0.00% | 0.00% | 0.00% | -0.36 | -0.40 | 1.21 | -0.07 |
| HSTM | HealthStream, Inc. | $21.23 | 629.85M | +76% | -51% | -73% | -65% | 34.97 | 1.81 | 2.11 | 8.98 | — | 8.96 | 64.74% | 6.66% | 6.03% | 5.14% | 5.38% | 3.56% | 0.04 | — | 0.96 | 0.77 | -0.32 | -758.00% | 426.00% | 10203.00% | 9.30% | 0.51 | 20.08% | 0.58% | 20.30% | 5.26% | 29.61 | 10.05 | 1.97 | 3.35 |
| IART | Integra LifeSciences Hold… | $11.38 | 886.41M | +457% | -63% | — | — | -1.55 | 0.77 | 0.49 | -1.58 | -0.02 | -1.13 | 51.69% | -30.17% | -31.58% | -39.90% | -21.27% | -13.52% | 0.21 | -5.72 | 2.54 | 1.19 | 0.04 | 736120.00% | 153.00% | -22439.00% | -3.88% | 0.11 | -1.46% | 0.00% | 0.00% | 219.53% | -1.53 | -24.24 | 0.46 | 0.59 |
| INNV | InnovAge Holding Corp. | $8.96 | 1.22B | +275% | -51% | -93% | — | -14.52 | 2.18 | 0.60 | 151.10 | -38.72 | 5.76 | 68.50% | -3.49% | -3.55% | -14.02% | -11.68% | -6.22% | 0.43 | -6.45 | 1.07 | 0.88 | 10.98 | 3750.00% | 1176.00% | -15937.00% | 5.18% | 0.20 | 10.44% | 0.00% | 0.00% | 5.16% | -17.08 | 19.11 | 0.60 | 2.17 |
| KURA | Kura Oncology, Inc. | $8.73 | 759.66M | — | — | — | — | -3.73 | 1.57 | 12.04 | 0.37 | — | 1.57 | 100.00% | -358.55% | -322.89% | -42.91% | 126.01% | -28.78% | 0.04 | -119.33 | 9.46 | 9.24 | 1.23 | -288.00% | — | -20708.00% | 20.63% | 1.71 | -87.30% | 0.00% | 0.00% | 28.94% | 0.32 | -0.46 | -1.15 | -0.24 |
| PROK | ProKidney Corp. | $2.24 | 277.76M | — | — | — | — | -0.63 | -0.10 | 1352.79 | 1.59 | -7.18 | -0.10 | 100.00% | -241678.95% | -80507.89% | 15.57% | 13.02% | -37.91% | 0.00 | -20408.44 | 10.93 | 9.96 | 0.60 | 877.00% | — | 2542.00% | -151.60% | -3.49 | 11.09% | 0.00% | 0.00% | 38.56% | 1.37 | 1.62 | -3319.00 | -2.64 |
| SNDA | Sonida Senior Living, Inc… | $35.89 | 673.64M | +237% | +24% | -86% | — | -105.95 | 2.82 | 1.14 | 12.59 | — | 3.53 | 89.12% | -4.87% | -0.68% | -11.61% | -2.25% | -0.45% | 5.29 | -0.40 | 0.85 | 0.48 | 8.13 | -8597.00% | 1919.00% | 27150.00% | -7.76% | -0.02 | -4.10% | 0.81% | -85.90% | 0.81% | -66.20 | -36.43 | 3.23 | -0.12 |
About The Pennant Group, Inc.
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
- CEO
- Brent J. Guerisoli
- Employees
- 7K
- Beta
- 1.28
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1,123.31 ÷ $31.30) − 1 = +3,488.85% (DCF, example).